VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q2423973 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000259.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q2423973‏
035 ‎‡a (OCoLC)Q2423973‏
043 ‎‡c US‏
046 ‎‡f 19000715‏ ‎‡g 19691001‏
100 1 ‎‡a Thomas Francis, Jr.‏ ‎‡c American physician, virologist, and epidemiologist (1900-1969)‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Τόμας Φράνσις ο νεώτερος‏ ‎‡c Αμερικανός ιατρός, ιολόγος και επιδημιολόγος‏ ‎‡9 el‏
400 0 ‎‡a Tiểu thác mã tư · phất lan tây tư ‏ ‎‡9 zh‏
400 0 ‎‡a توماس فرانسيس الأصغر‏ ‎‡c طبيب وعالم أمريكي‏ ‎‡9 ar‏
400 0 ‎‡a Томас Френсис‏ ‎‡9 ru‏
400 0 ‎‡a Thomas Francis junior‏ ‎‡c Amerikaans viroloog (1900-1969)‏ ‎‡9 nl‏
400 0 ‎‡a Thomas Francis junior‏ ‎‡c US-amerikanischer Arzt, Virologe und Epidemiologe‏ ‎‡9 de‏
400 0 ‎‡a توماس فرانسیس جونیور‏ ‎‡9 fa‏
400 0 ‎‡a תומאס פרנסיס הבן‏ ‎‡9 he‏
400 0 ‎‡a തോമസ് ഫ്രാൻസിസ് ജൂനിയർ‏ ‎‡9 ml‏
400 0 ‎‡a Thomas Francis mlajši‏ ‎‡9 sl‏
670 ‎‡a Author's A NEW TYPE OF VIRUS FROM EPIDEMIC INFLUENZA.‏
670 ‎‡a Author's A RATIONALE FOR STUDIES IN THE CONTROL OF EPIDEMIC INFLUENZA‏
670 ‎‡a Author's A serological recapitulation of human infection with different strains of influenza virus‏
670 ‎‡a Author's A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS.‏
670 ‎‡a Author's ACTH in experimental poliomyelitis in monkeys and mice‏
670 ‎‡a Author's An experience with vaccination against influenza B in 1952 by use of monovalent vaccine‏
670 ‎‡a Author's An experience with vaccination against influenza B in 1952 using monovalent vaccine‏
670 ‎‡a Author's AN UNIDENTIFIED VIRUS PRODUCING ACUTE MENINGITIS AND PNEUMONITIS IN EXPERIMENTAL ANIMALS.‏
670 ‎‡a Author's Antigen-antibody precipitates in solid medium with influenza virus.‏
670 ‎‡a Author's Antiviral action of a mold filtrate on experimental poliomyelitis in cynomolgus monkeys‏
670 ‎‡a Author's Antiviral action of helenine on experimental poliomyelitis‏
670 ‎‡a Author's CULTIVATION OF HUMAN INFLUENZA VIRUS IN AN ARTIFICIAL MEDIUM.‏
670 ‎‡a Author's Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.*‏
670 ‎‡a Author's [Distribution of Asian influenza and its recurrences. Study of morbidity in population centers and in individual families]‏
670 ‎‡a Author's Effect of fluoroacetate upon poliomyelitis in monkeys‏
670 ‎‡a Author's Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic‏
670 ‎‡a Author's Epidemiology of influenza; comparative serological observations in England and the United States‏
670 ‎‡a Author's Etiological and Serological Studies in Epidemic Influenza‏
670 ‎‡a Author's Evaluation of the effect of darvisul upon infection with SK strain of virus in mice.‏
670 ‎‡a Author's Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report‏
670 ‎‡a Author's Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.‏
670 ‎‡a Author's HOMOLOGOUS AND HETEROLOGOUS ANTIBODY RESPONSE OF INFANTS AND CHILDREN TO MULTIPLE INJECTIONS OF A SINGLE STRAIN OF INFLUENZA VIRUS.‏
670 ‎‡a Author's Identification of another epidemic respiratory disease‏
670 ‎‡a Author's Immunity in Human Subjects Artificially Infected with Influenza Virus, Type B.‏
670 ‎‡a Author's Immunization against influenza‏
670 ‎‡a Author's Immunization against influenza with observations during an epidemic of influenza A one year after vaccination‏
670 ‎‡a Author's IMMUNOLOGICAL STUDIES WITH THE VIRUS OF INFLUENZA.‏
670 ‎‡a Author's Influence of primary antigenic experience upon the development of a broad immunity to influenza‏
670 ‎‡a Author's Influence of saliva upon hemagglutination by influenza virus.‏
670 ‎‡a Author's Interim report, Public Health Service Technical Committee on Poliomyelitis Vaccine‏
670 ‎‡a Author's Interpretations of influenza antibody patterns of man‏
670 ‎‡a Author's Laboratory and clinical characteristics of attenuated strains of influenza virus‏
670 ‎‡a Author's MECHANISMS OF INFECTION AND IMMUNITY IN VIRUS DISEASES OF MAN.‏
670 ‎‡a Author's Mobilization against Influenza‏
670 ‎‡a Author's Protective Effect of Vaccination Against Induced Influenza A‏
670 ‎‡a Author's PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA B.‏
670 ‎‡a Author's Reactions to an influenza virus vaccine in infants and children.‏
670 ‎‡a Author's Resemblance of a strain of swine influenza virus to human A-prime strains‏
670 ‎‡a Author's RIFT VALLEY FEVER: A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS.‏
670 ‎‡a Author's Search for extrahuman sources of poliomyelitis virus‏
670 ‎‡a Author's Serologic comparisons with lines of influenza virus isolated and serially transferred in different experimental hosts.‏
670 ‎‡a Author's SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN.‏
670 ‎‡a Author's Serum alkaline phosphatase in monkeys and man during poliomyelitis‏
670 ‎‡a Author's Studies of the distribution of poliomyelitis virus: in rural schools following an epidemic‏
670 ‎‡a Author's STUDIES OF THE DISTRIBUTION OF POLIOMYELITIS VIRUS: V. THE VIRUS IN FAMILIAL ASSOCIATES OF CASES.‏
670 ‎‡a Author's Studies of the distribution of poliomyelitis virus. VI. In a small community in an epidemic area.‏
670 ‎‡a Author's Studies on the relation of wild rats to poliomyelitis‏
670 ‎‡a Author's STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM.‏
670 ‎‡a Author's THE ACTION OF IMMUNE SERUM ON HUMAN INFLUENZA VIRUS IN VITRO‏
670 ‎‡a Author's The action of terramycin on the growth of strains of influenza, herpes simplex, and rabies viruses in chick embryos and mice‏
670 ‎‡a Author's THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.‏
670 ‎‡a Author's THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION.‏
670 ‎‡a Author's THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS.‏
670 ‎‡a Author's THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR HUMAN INFLUENZA VIRUS IN THE SERUM OF HUMAN INDIVIDUALS OF DIFFERENT AGES‏
670 ‎‡a Author's The incidence of poliomyelitis virus in cases of mild illness during a severe urban epidemic.‏
670 ‎‡a Author's The protective effect of vaccination against epidemic influenza B‏
670 ‎‡a Author's THE VIRUS-NEUTRALIZING ACTION OF SERUM FROM MICE INFECTED WITH POLIOMYELITIS VIRUS‏
670 ‎‡a Author's TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.‏
670 ‎‡a Author's Type C influenza virus. I. Studies of the virus and its distribution.‏
670 ‎‡a Author's Type C influenza virus. II. Intranasal inoculation of human individuals.‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/FAST|1753665‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/22145376469183721111‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/LC|n 87843048‏
670 ‎‡a wikidata site links‏ ‎‡u https://ar.wikipedia.org/wiki/توماس_فرانسيس_الأصغر‏
670 ‎‡a wikidata site links‏ ‎‡u https://zh.wikipedia.org/wiki/ tiểu thác mã tư · phất lan tây tư ‏
670 ‎‡a wikidata site links‏ ‎‡u https://fa.wikipedia.org/wiki/توماس_فرانسیس‏
670 ‎‡a wikidata site links‏ ‎‡u https://de.wikipedia.org/wiki/Thomas_Francis_junior‏
670 ‎‡a wikidata site links‏ ‎‡u https://es.wikipedia.org/wiki/Thomas_Francis,_Jr.‏
670 ‎‡a wikidata site links‏ ‎‡u https://ml.wikipedia.org/wiki/തോമസ്_ഫ്രാൻസിസ്_ജൂനിയർ‏
670 ‎‡a wikidata site links‏ ‎‡u https://en.wikipedia.org/wiki/Thomas_Francis_Jr.‏
670 ‎‡a wikidata site links‏ ‎‡u https://ca.wikipedia.org/wiki/Thomas_Francis_Jr.‏
919 ‎‡a searchforextrahumansourcesofpoliomyelitisvirus‏ ‎‡A Search for extrahuman sources of poliomyelitis virus‏ ‎‡9 1‏
919 ‎‡a newtypeofvirusfromepidemicinfluenza‏ ‎‡A A NEW TYPE OF VIRUS FROM EPIDEMIC INFLUENZA.‏ ‎‡9 1‏
919 ‎‡a rationaleforstudiesinthecontrolofepidemicinfluenza‏ ‎‡A A RATIONALE FOR STUDIES IN THE CONTROL OF EPIDEMIC INFLUENZA‏ ‎‡9 1‏
919 ‎‡a serologicalrecapitulationofhumaninfectionwithdifferentstrainsofinfluenzavirus‏ ‎‡A A serological recapitulation of human infection with different strains of influenza virus‏ ‎‡9 1‏
919 ‎‡a simplifiedprocedurefortheconcentrationandpurificationofinfluenzavirus‏ ‎‡A A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS.‏ ‎‡9 1‏
919 ‎‡a acthinexperimentalpoliomyelitisinmonkeysandmice‏ ‎‡A ACTH in experimental poliomyelitis in monkeys and mice‏ ‎‡9 1‏
919 ‎‡a experiencewithvaccinationagainstinfluenzabin1952byuseofmonovalentvaccine‏ ‎‡A An experience with vaccination against influenza B in 1952 by use of monovalent vaccine‏ ‎‡9 1‏
919 ‎‡a experiencewithvaccinationagainstinfluenzabin1952usingmonovalentvaccine‏ ‎‡A An experience with vaccination against influenza B in 1952 using monovalent vaccine‏ ‎‡9 1‏
919 ‎‡a unidentifiedvirusproducingacutemeningitisandpneumonitisinexperimentalanimals‏ ‎‡A AN UNIDENTIFIED VIRUS PRODUCING ACUTE MENINGITIS AND PNEUMONITIS IN EXPERIMENTAL ANIMALS.‏ ‎‡9 1‏
919 ‎‡a antigenantibodyprecipitatesinsolidmediumwithinfluenzavirus‏ ‎‡A Antigen-antibody precipitates in solid medium with influenza virus.‏ ‎‡9 1‏
919 ‎‡a antiviralactionofamoldfiltrateonexperimentalpoliomyelitisincynomolgusmonkeys‏ ‎‡A Antiviral action of a mold filtrate on experimental poliomyelitis in cynomolgus monkeys‏ ‎‡9 1‏
919 ‎‡a antiviralactionofhelenineonexperimentalpoliomyelitis‏ ‎‡A Antiviral action of helenine on experimental poliomyelitis‏ ‎‡9 1‏
919 ‎‡a cultivationofhumaninfluenzavirusinanartificialmedium‏ ‎‡A CULTIVATION OF HUMAN INFLUENZA VIRUS IN AN ARTIFICIAL MEDIUM.‏ ‎‡9 1‏
919 ‎‡a demonstrationofinfectioushepatitisvirusinpresymptomaticperiodaftertransferbytransfusion‏ ‎‡A Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.*‏ ‎‡9 1‏
919 ‎‡a distributionofasianinfluenzaanditsrecurrencesstudyofmorbidityinpopulationcentersandinindividualfamilies‏ ‎‡A [Distribution of Asian influenza and its recurrences. Study of morbidity in population centers and in individual families]‏ ‎‡9 1‏
919 ‎‡a effectoffluoroacetateuponpoliomyelitisinmonkeys‏ ‎‡A Effect of fluoroacetate upon poliomyelitis in monkeys‏ ‎‡9 1‏
919 ‎‡a effectofvaccinationofaschoolagepopulationuponthecourseofana2hongkonginfluenzaepidemic‏ ‎‡A Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic‏ ‎‡9 1‏
919 ‎‡a epidemiologyofinfluenzacomparativeserologicalobservationsinenglandandtheunitedstates‏ ‎‡A Epidemiology of influenza; comparative serological observations in England and the United States‏ ‎‡9 1‏
919 ‎‡a etiologicalandserologicalstudiesinepidemicinfluenza‏ ‎‡A Etiological and Serological Studies in Epidemic Influenza‏ ‎‡9 1‏
919 ‎‡a evaluationoftheeffectofdarvisuluponinfectionwithskstrainofvirusinmice‏ ‎‡A Evaluation of the effect of darvisul upon infection with SK strain of virus in mice.‏ ‎‡9 1‏
919 ‎‡a experiencewithvaccinationagainstinfluenzainthespringof1947apreliminaryreport‏ ‎‡A Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report‏ ‎‡9 1‏
919 ‎‡a failuretodemonstrateantibodyinfecesofmonkeysvaccinatedwithpoliomyelitisviruslansingstrain‏ ‎‡A Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.‏ ‎‡9 1‏
919 ‎‡a homologousandheterologousantibodyresponseofinfantsandchildrentomultipleinjectionsofasinglestrainofinfluenzavirus‏ ‎‡A HOMOLOGOUS AND HETEROLOGOUS ANTIBODY RESPONSE OF INFANTS AND CHILDREN TO MULTIPLE INJECTIONS OF A SINGLE STRAIN OF INFLUENZA VIRUS.‏ ‎‡9 1‏
919 ‎‡a identificationofanotherepidemicrespiratorydisease‏ ‎‡A Identification of another epidemic respiratory disease‏ ‎‡9 1‏
919 ‎‡a immunityinhumansubjectsartificiallyinfectedwithinfluenzavirustypeb‏ ‎‡A Immunity in Human Subjects Artificially Infected with Influenza Virus, Type B.‏ ‎‡9 1‏
919 ‎‡a immunizationagainstinfluenza‏ ‎‡A Immunization against influenza‏ ‎‡9 1‏
919 ‎‡a immunizationagainstinfluenzawithobservationsduringanepidemicofinfluenzaa1yearaftervaccination‏ ‎‡A Immunization against influenza with observations during an epidemic of influenza A one year after vaccination‏ ‎‡9 1‏
919 ‎‡a immunologicalstudieswiththevirusofinfluenza‏ ‎‡A IMMUNOLOGICAL STUDIES WITH THE VIRUS OF INFLUENZA.‏ ‎‡9 1‏
919 ‎‡a influenceofprimaryantigenicexperienceuponthedevelopmentofabroadimmunitytoinfluenza‏ ‎‡A Influence of primary antigenic experience upon the development of a broad immunity to influenza‏ ‎‡9 1‏
919 ‎‡a influenceofsalivauponhemagglutinationbyinfluenzavirus‏ ‎‡A Influence of saliva upon hemagglutination by influenza virus.‏ ‎‡9 1‏
919 ‎‡a interimreportpublichealthservicetechnicalcommitteeonpoliomyelitisvaccine‏ ‎‡A Interim report, Public Health Service Technical Committee on Poliomyelitis Vaccine‏ ‎‡9 1‏
919 ‎‡a interpretationsofinfluenzaantibodypatternsofman‏ ‎‡A Interpretations of influenza antibody patterns of man‏ ‎‡9 1‏
919 ‎‡a laboratoryandclinicalcharacteristicsofattenuatedstrainsofinfluenzavirus‏ ‎‡A Laboratory and clinical characteristics of attenuated strains of influenza virus‏ ‎‡9 1‏
919 ‎‡a mechanismsofinfectionandimmunityinvirusdiseasesofman‏ ‎‡A MECHANISMS OF INFECTION AND IMMUNITY IN VIRUS DISEASES OF MAN.‏ ‎‡9 1‏
919 ‎‡a mobilizationagainstinfluenza‏ ‎‡A Mobilization against Influenza‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofvaccinationagainstinducedinfluenzaa‏ ‎‡A Protective Effect of Vaccination Against Induced Influenza A‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofvaccinationagainstinducedinfluenzab‏ ‎‡A PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA B.‏ ‎‡9 1‏
919 ‎‡a reactionstoaninfluenzavirusvaccineininfantsandchildren‏ ‎‡A Reactions to an influenza virus vaccine in infants and children.‏ ‎‡9 1‏
919 ‎‡a resemblanceofastrainofswineinfluenzavirustohumanaprimestrains‏ ‎‡A Resemblance of a strain of swine influenza virus to human A-prime strains‏ ‎‡9 1‏
919 ‎‡a riftvalleyfeverareportof3casesoflaboratoryinfectionandtheexperimentaltransmissionofthediseasetoferrets‏ ‎‡A RIFT VALLEY FEVER: A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS.‏ ‎‡9 1‏
919 ‎‡a serologiccomparisonswithlinesofinfluenzavirusisolatedandseriallytransferredindifferentexperimentalhosts‏ ‎‡A Serologic comparisons with lines of influenza virus isolated and serially transferred in different experimental hosts.‏ ‎‡9 1‏
919 ‎‡a serologicalresponsetointranasaladministrationofinactiveinfluenzavirusinchildren‏ ‎‡A SEROLOGICAL RESPONSE TO INTRANASAL ADMINISTRATION OF INACTIVE INFLUENZA VIRUS IN CHILDREN.‏ ‎‡9 1‏
919 ‎‡a serumalkalinephosphataseinmonkeysandmanduringpoliomyelitis‏ ‎‡A Serum alkaline phosphatase in monkeys and man during poliomyelitis‏ ‎‡9 1‏
919 ‎‡a studiesofthedistributionofpoliomyelitisvirusinruralschoolsfollowinganepidemic‏ ‎‡A Studies of the distribution of poliomyelitis virus: in rural schools following an epidemic‏ ‎‡9 1‏
919 ‎‡a studiesofthedistributionofpoliomyelitisvirus5thevirusinfamilialassociatesofcases‏ ‎‡A STUDIES OF THE DISTRIBUTION OF POLIOMYELITIS VIRUS: V. THE VIRUS IN FAMILIAL ASSOCIATES OF CASES.‏ ‎‡9 1‏
919 ‎‡a studiesofthedistributionofpoliomyelitisvirus6inasmallcommunityinanepidemicarea‏ ‎‡A Studies of the distribution of poliomyelitis virus. VI. In a small community in an epidemic area.‏ ‎‡9 1‏
919 ‎‡a studiesontherelationofwildratstopoliomyelitis‏ ‎‡A Studies on the relation of wild rats to poliomyelitis‏ ‎‡9 1‏
919 ‎‡a studieswithhumaninfluenzaviruscultivatedinartificialmedium‏ ‎‡A STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM.‏ ‎‡9 1‏
919 ‎‡a actionofimmuneserumonhumaninfluenzavirusinvitro‏ ‎‡A THE ACTION OF IMMUNE SERUM ON HUMAN INFLUENZA VIRUS IN VITRO‏ ‎‡9 1‏
919 ‎‡a actionofterramycinonthegrowthofstrainsofinfluenzaherpessimplexandrabiesvirusesinchickembryosandmice‏ ‎‡A The action of terramycin on the growth of strains of influenza, herpes simplex, and rabies viruses in chick embryos and mice‏ ‎‡9 1‏
919 ‎‡a antibodyresponseofhumansubjectsvaccinatedwiththevirusofhumaninfluenza‏ ‎‡A THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.‏ ‎‡9 1‏
919 ‎‡a antigenicpotencyofepidemicinfluenzavirusfollowinginactivationbyultravioletradiation‏ ‎‡A THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION.‏ ‎‡9 1‏
919 ‎‡a inactivationofepidemicinfluenzavirusbynasalsecretionsofhumanindividuals‏ ‎‡A THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS.‏ ‎‡9 1‏
919 ‎‡a incidenceofneutralizingantibodiesforhumaninfluenzavirusintheserumofhumanindividualsofdifferentages‏ ‎‡A THE INCIDENCE OF NEUTRALIZING ANTIBODIES FOR HUMAN INFLUENZA VIRUS IN THE SERUM OF HUMAN INDIVIDUALS OF DIFFERENT AGES‏ ‎‡9 1‏
919 ‎‡a incidenceofpoliomyelitisvirusincasesofmildillnessduringasevereurbanepidemic‏ ‎‡A The incidence of poliomyelitis virus in cases of mild illness during a severe urban epidemic.‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofvaccinationagainstepidemicinfluenzab‏ ‎‡A The protective effect of vaccination against epidemic influenza B‏ ‎‡9 1‏
919 ‎‡a virusneutralizingactionofserumfrommiceinfectedwithpoliomyelitisvirus‏ ‎‡A THE VIRUS-NEUTRALIZING ACTION OF SERUM FROM MICE INFECTED WITH POLIOMYELITIS VIRUS‏ ‎‡9 1‏
919 ‎‡a transmissionofinfluenzabyafilterablevirus‏ ‎‡A TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.‏ ‎‡9 1‏
919 ‎‡a type100influenzavirus1studiesofthevirusanditsdistribution‏ ‎‡A Type C influenza virus. I. Studies of the virus and its distribution.‏ ‎‡9 1‏
919 ‎‡a type100influenzavirus2intranasalinoculationofhumanindividuals‏ ‎‡A Type C influenza virus. II. Intranasal inoculation of human individuals.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
947 ‎‡a US‏ ‎‡9 1‏
996 ‎‡2 LIH|LNB:B8_y_1;=B_a_‏
996 ‎‡2 LC|n 88632917‏
996 ‎‡2 CAOONL|ncf11742822‏
996 ‎‡2 ISNI|0000000053080009‏
996 ‎‡2 NII|DA05637810‏
996 ‎‡2 DNB|172278821‏
996 ‎‡2 LC|no2021085042‏
996 ‎‡2 NKC|ntk2013785780‏
996 ‎‡2 LC|no 98074349‏
996 ‎‡2 BNF|14057899‏
996 ‎‡2 BNF|12212817‏
996 ‎‡2 CAOONL|ncf10298231‏
996 ‎‡2 LC|n 77017141‏
996 ‎‡2 NII|DA06938266‏
996 ‎‡2 BIBSYS|90894473‏
996 ‎‡2 NTA|070126968‏
996 ‎‡2 N6I|vtls000259027‏
996 ‎‡2 BIBSYS|90144433‏
996 ‎‡2 BNF|12015535‏
996 ‎‡2 DNB|1158216106‏
996 ‎‡2 DNB|1058624202‏
996 ‎‡2 NUKAT|n 2010103727‏
996 ‎‡2 LC|n 82050318‏
996 ‎‡2 W2Z|15034832‏
996 ‎‡2 ISNI|0000000024692145‏
996 ‎‡2 LC|n 84213183‏
996 ‎‡2 DNB|1093190809‏
996 ‎‡2 LC|n 99275987‏
996 ‎‡2 LC|n 2014003263‏
996 ‎‡2 SUDOC|266633471‏
996 ‎‡2 J9U|987007319721405171‏
996 ‎‡2 BIBSYS|90965261‏
996 ‎‡2 NUKAT|n 2022172337‏
996 ‎‡2 N6I|vtls001365753‏
996 ‎‡2 ISNI|0000000046220712‏
996 ‎‡2 LC|n 2016014092‏
996 ‎‡2 ISNI|0000000122076442‏
996 ‎‡2 NII|DA02952491‏
996 ‎‡2 DNB|1228152152‏
996 ‎‡2 BNF|12990346‏
996 ‎‡2 B2Q|0000295234‏
996 ‎‡2 SUDOC|229976972‏
996 ‎‡2 LC|n 00121630‏
996 ‎‡2 ISNI|0000000047811258‏
996 ‎‡2 NTA|074803247‏
996 ‎‡2 NUKAT|n 2019065355‏
996 ‎‡2 PTBNP|1212498‏
996 ‎‡2 LC|no2013113871‏
996 ‎‡2 LC|n 2014049741‏
996 ‎‡2 LC|n 85141133‏
996 ‎‡2 SUDOC|26229396X‏
996 ‎‡2 NII|DA19436748‏
996 ‎‡2 DNB|1052477577‏
996 ‎‡2 LC|n 96008882‏
996 ‎‡2 ISNI|0000000122823209‏
996 ‎‡2 ISNI|0000000430252882‏
996 ‎‡2 BNF|10419651‏
996 ‎‡2 RERO|A012958834‏
996 ‎‡2 NUKAT|n 2009077581‏
996 ‎‡2 BNF|13560691‏
996 ‎‡2 NSK|000269826‏
996 ‎‡2 DNB|134127188‏
996 ‎‡2 BIBSYS|90237254‏
996 ‎‡2 NII|DA1039910X‏
996 ‎‡2 SUDOC|097875848‏
996 ‎‡2 LC|no2014151445‏
996 ‎‡2 NTA|083816801‏
996 ‎‡2 ISNI|0000000436172488‏
996 ‎‡2 ISNI|0000000039710633‏
996 ‎‡2 BNF|15081503‏
996 ‎‡2 PLWABN|9810616860905606‏
996 ‎‡2 LC|n 87884982‏
996 ‎‡2 PTBNP|132536‏
996 ‎‡2 LC|n 2011085238‏
996 ‎‡2 BNE|XX4608045‏
996 ‎‡2 LC|nb2018001013‏
996 ‎‡2 BIBSYS|90234550‏
996 ‎‡2 DNB|123255821‏
996 ‎‡2 LC|no2010109958‏
996 ‎‡2 J9U|987007446536105171‏
996 ‎‡2 SUDOC|259316032‏
996 ‎‡2 ISNI|0000000068793765‏
996 ‎‡2 N6I|vtls001313105‏
996 ‎‡2 J9U|987007451237205171‏
996 ‎‡2 BNF|16433131‏
996 ‎‡2 NTA|071917500‏
996 ‎‡2 NUKAT|n 2008073804‏
996 ‎‡2 BIBSYS|15034832‏
996 ‎‡2 ISNI|0000000436851560‏
996 ‎‡2 J9U|987007341748205171‏
996 ‎‡2 LC|no2011184599‏
996 ‎‡2 PTBNP|242145‏
996 ‎‡2 SUDOC|251653331‏
996 ‎‡2 LC|no 89021028‏
996 ‎‡2 NII|DA13700821‏
996 ‎‡2 N6I|vtls001299834‏
996 ‎‡2 SUDOC|234337443‏
996 ‎‡2 ISNI|000000011597106X‏
996 ‎‡2 LC|n 2001080137‏
996 ‎‡2 BNF|13483060‏
996 ‎‡2 BIBSYS|3011623‏
996 ‎‡2 ISNI|0000000384335950‏
996 ‎‡2 NII|DA02680824‏
996 ‎‡2 LC|n 2013216136‏
996 ‎‡2 SUDOC|245326308‏
996 ‎‡2 NDL|01155366‏
996 ‎‡2 SUDOC|258216948‏
996 ‎‡2 ISNI|0000000081454557‏
996 ‎‡2 NUKAT|n 2018249541‏
996 ‎‡2 DNB|1137860561‏
996 ‎‡2 NUKAT|n 2018290707‏
996 ‎‡2 SUDOC|243407955‏
996 ‎‡2 ISNI|0000000034390052‏
996 ‎‡2 LC|n 85194779‏
996 ‎‡2 ISNI|0000000373301288‏
996 ‎‡2 ISNI|0000000073828803‏
996 ‎‡2 ISNI|0000000114107536‏
996 ‎‡2 LC|nb2007018256‏
996 ‎‡2 BIBSYS|90800581‏
996 ‎‡2 CAOONL|ncf11330477‏
996 ‎‡2 LC|nb2009026379‏
996 ‎‡2 J9U|987007362708705171‏
996 ‎‡2 JPG|500053396‏
996 ‎‡2 NTA|173612245‏
996 ‎‡2 SUDOC|20166478X‏
996 ‎‡2 ISNI|0000000384792502‏
996 ‎‡2 NTA|251137481‏
996 ‎‡2 BIBSYS|90560288‏
996 ‎‡2 CAOONL|ncf10088601‏
996 ‎‡2 SUDOC|155014919‏
996 ‎‡2 LC|n 86079303‏
996 ‎‡2 BIBSYS|90259173‏
996 ‎‡2 ISNI|0000000078400339‏
996 ‎‡2 BIBSYS|90307214‏
996 ‎‡2 LC|nb 97064981‏
996 ‎‡2 LC|no2023069320‏
996 ‎‡2 BIBSYS|90542273‏
996 ‎‡2 RERO|A003897436‏
996 ‎‡2 DNB|127986618‏
996 ‎‡2 NSK|000273731‏
996 ‎‡2 NTA|402303571‏
996 ‎‡2 BIBSYS|1675320984003‏
996 ‎‡2 LC|nr 91034432‏
996 ‎‡2 ISNI|0000000038928411‏
996 ‎‡2 LC|no2020134954‏
996 ‎‡2 ISNI|0000000043542804‏
996 ‎‡2 RERO|A011575973‏
996 ‎‡2 LC|n 80055853‏
996 ‎‡2 ISNI|0000000069213160‏
996 ‎‡2 LC|n 96007312‏
996 ‎‡2 LC|no 00047038‏
996 ‎‡2 ISNI|0000000368897240‏
996 ‎‡2 LC|no2006089550‏
996 ‎‡2 ISNI|0000000025429496‏
996 ‎‡2 BIBSYS|98057658‏
996 ‎‡2 J9U|987012330049305171‏
996 ‎‡2 RERO|A003897435‏
996 ‎‡2 RERO|A003897434‏
996 ‎‡2 LIH|LNB:B_w__m_D;=B6‏
996 ‎‡2 SUDOC|092785840‏
996 ‎‡2 RERO|A003897431‏
996 ‎‡2 BNCHL|10000000000000000171582‏
996 ‎‡2 ISNI|0000000063057582‏
996 ‎‡2 RERO|A003897432‏
996 ‎‡2 LC|n 87846777‏
996 ‎‡2 RERO|A012436455‏
996 ‎‡2 PLWABN|9812833502705606‏
996 ‎‡2 BNF|16433133‏
996 ‎‡2 BNF|13736955‏
996 ‎‡2 NTA|31491756X‏
996 ‎‡2 ISNI|0000000107532905‏
996 ‎‡2 NII|DA12213574‏
996 ‎‡2 ISNI|0000000389641412‏
996 ‎‡2 LC|no2012027699‏
996 ‎‡2 SUDOC|119821583‏
996 ‎‡2 J9U|987007357877605171‏
996 ‎‡2 ISNI|0000000370064192‏
996 ‎‡2 SUDOC|155505033‏
996 ‎‡2 LC|n 82003930‏
996 ‎‡2 LC|nb2010013493‏
996 ‎‡2 LC|no2023065984‏
996 ‎‡2 BIBSYS|90304709‏
996 ‎‡2 SUDOC|118683403‏
996 ‎‡2 NUKAT|n 2022078411‏
996 ‎‡2 ISNI|0000000395259412‏
996 ‎‡2 BIBSYS|43439‏
996 ‎‡2 NTA|074696157‏
996 ‎‡2 LC|n 00121360‏
996 ‎‡2 DNB|1057278122‏
996 ‎‡2 LC|nr 97005163‏
996 ‎‡2 NUKAT|n 2012062783‏
996 ‎‡2 LC|nb 98067509‏
996 ‎‡2 DNB|1157863574‏
996 ‎‡2 ISNI|0000000023431672‏
996 ‎‡2 RERO|A003897429‏
996 ‎‡2 SUDOC|150299680‏
996 ‎‡2 DNB|1076179533‏
996 ‎‡2 LC|n 2022180284‏
996 ‎‡2 J9U|987007330831605171‏
996 ‎‡2 NII|DA04561021‏
996 ‎‡2 BIBSYS|90613361‏
996 ‎‡2 RERO|A003897426‏
996 ‎‡2 RERO|A003897427‏
996 ‎‡2 RERO|A003897425‏
996 ‎‡2 CAOONL|ncf10379973‏
996 ‎‡2 RERO|A003897428‏
996 ‎‡2 BIBSYS|14058248‏
996 ‎‡2 ISNI|000000039046613X‏
996 ‎‡2 SUDOC|177132450‏
996 ‎‡2 DE633|pe30113378‏
996 ‎‡2 SUDOC|187470618‏
996 ‎‡2 NTA|340479981‏
996 ‎‡2 BIBSYS|9001704‏
996 ‎‡2 CAOONL|ncf10051688‏
996 ‎‡2 RERO|A003897430‏
996 ‎‡2 PTBNP|1650151‏
996 ‎‡2 LC|no2014086340‏
996 ‎‡2 ISNI|0000000025302997‏
996 ‎‡2 CAOONL|ncf11563022‏
996 ‎‡2 NLA|000035729353‏
996 ‎‡2 ISNI|0000000112055402‏
996 ‎‡2 BIBSYS|90105516‏
996 ‎‡2 LC|no2011187146‏
996 ‎‡2 PTBNP|1463350‏
996 ‎‡2 ISNI|0000000432786837‏
996 ‎‡2 LC|n 2004152061‏
996 ‎‡2 LC|no2018165689‏
996 ‎‡2 SUDOC|168090414‏
996 ‎‡2 RERO|A011509768‏
996 ‎‡2 LC|n 94122694‏
996 ‎‡2 NUKAT|n 2006140131‏
996 ‎‡2 BIBSYS|90622132‏
996 ‎‡2 LC|n 81007127‏
996 ‎‡2 NII|DA03359557‏
996 ‎‡2 ISNI|0000000368733588‏
996 ‎‡2 BNF|15560490‏
996 ‎‡2 ISNI|0000000459545128‏
996 ‎‡2 SUDOC|243238576‏
996 ‎‡2 BNC|981058518626106706‏
996 ‎‡2 ISNI|0000000032566632‏
996 ‎‡2 ISNI|0000000506849475‏
996 ‎‡2 LC|n 90679785‏
996 ‎‡2 BNE|XX955754‏
996 ‎‡2 LC|nb2016013291‏
996 ‎‡2 DNB|1157520634‏
996 ‎‡2 LC|n 79066820‏
996 ‎‡2 LC|n 90673933‏
996 ‎‡2 W2Z|1675320984003‏
996 ‎‡2 LC|no2007006713‏
996 ‎‡2 J9U|987007323924805171‏
997 ‎‡a 1900 1969 lived 0715 1001‏ ‎‡9 1‏
998 ‎‡a Francis, Thomas,‏ ‎‡c Jr.,‏ ‎‡2 LC|n 87843048‏ ‎‡3 suggested‏
998 ‎‡a Thomas Francis, Jr‏ ‎‡c American physician, virologist, and epidemiologist‏ ‎‡2 ISNI|0000000455290324‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Francis, Thomas‏ ‎‡c Jr‏ ‎‡2 ISNI|0000000455290324‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Thomas, John Heywood‏ ‎‡2 DNB|138941149‏ ‎‡3 double date‏
998 ‎‡a Thomas, John Heywood‏ ‎‡2 ISNI|0000000080077032‏ ‎‡3 double date‏